WO2008072891A1 - Micro-organisme presentant une activite enzymatique inactivee pour nrfe et procede de production de l-tryptophane au moyen de ce micro-organisme - Google Patents
Micro-organisme presentant une activite enzymatique inactivee pour nrfe et procede de production de l-tryptophane au moyen de ce micro-organisme Download PDFInfo
- Publication number
- WO2008072891A1 WO2008072891A1 PCT/KR2007/006462 KR2007006462W WO2008072891A1 WO 2008072891 A1 WO2008072891 A1 WO 2008072891A1 KR 2007006462 W KR2007006462 W KR 2007006462W WO 2008072891 A1 WO2008072891 A1 WO 2008072891A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tryptophan
- gene
- producing
- nrffi
- microorganism
- Prior art date
Links
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 title claims abstract description 84
- 244000005700 microbiome Species 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title description 15
- 108090000790 Enzymes Proteins 0.000 title description 4
- 102000004190 Enzymes Human genes 0.000 title description 4
- 230000008569 process Effects 0.000 title description 4
- 230000000694 effects Effects 0.000 title description 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 49
- 229960004799 tryptophan Drugs 0.000 claims abstract description 39
- 241000588724 Escherichia coli Species 0.000 claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 claims abstract description 11
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims abstract description 4
- 230000001419 dependent effect Effects 0.000 claims abstract description 4
- 108010025915 Nitrite Reductases Proteins 0.000 claims abstract description 3
- 241000186249 Corynebacterium sp. Species 0.000 claims description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 2
- 241000588774 Providencia sp. Species 0.000 claims description 2
- 241000607714 Serratia sp. Species 0.000 claims description 2
- 230000009467 reduction Effects 0.000 claims description 2
- 230000000415 inactivating effect Effects 0.000 abstract description 5
- 239000012634 fragment Substances 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 12
- 230000002779 inactivation Effects 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 230000006801 homologous recombination Effects 0.000 description 4
- 238000002744 homologous recombination Methods 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 102100030497 Cytochrome c Human genes 0.000 description 2
- 108010075031 Cytochromes c Proteins 0.000 description 2
- 238000012270 DNA recombination Methods 0.000 description 2
- 241001646716 Escherichia coli K-12 Species 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 229960005091 chloramphenicol Drugs 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 101150044432 nrfE gene Proteins 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- LBMAEBPZXXNKMZ-UHFFFAOYSA-N 2-amino-n-hydroxy-3-(1h-indol-3-yl)propanamide Chemical compound C1=CC=C2C(CC(N)C(=O)NO)=CNC2=C1 LBMAEBPZXXNKMZ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 101150035339 nrfG gene Proteins 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920001522 polyglycol ester Polymers 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
- C12P13/227—Tryptophan
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y107/00—Oxidoreductases acting on other nitrogenous compounds as donors (1.7)
- C12Y107/01—Oxidoreductases acting on other nitrogenous compounds as donors (1.7) with NAD+ or NADP+ as acceptor (1.7.1)
- C12Y107/01004—Nitrite reductase [NAD(P)H] (1.7.1.4)
Definitions
- the present invention relates to a microorganism producing L-tryptophan and a method for producing L-tryptophan using the same, more particularly a recombinant microorganism with improved L-tryptophan productivity by inactivating its nrffi gene encoding formate-dependent nitrite reductase originated from E. coli and a method for producing L-tryptophan using the same.
- Background Art
- L-tryptophan is one of essential amino acids, which has been used as a feed additive or a raw material for medicines including injections and health foods owing to its hypnotic or tranquilizing effect.
- a method for producing L-tryptophan is exemplified by chemical synthesis, enzyme reaction and microorganism fermentation.
- chemical synthesis high temperature and high pressure reaction is required and as a result both D type and L type are included in the reaction product, which makes the purification process difficult.
- Enzyme reaction has problems of high price of indole and serine used as substrates and of instability of the enzyme, as shown in the patent description of Mitsui Toatsu (Korean Patent Publication No. 90-005773).
- the main object of the method using an L-tryptophan analog resistant strain is to overcome the feed-back inhibition of tryptophan synthesis mediated by metabolites.
- the main object of the method using a recombinant strain is to increase the productivity/yield of tryptophan by amplifying major enzymes, which was in fact quite successful.
- the present invention provides a recombinant microorganism producing L-tryptophan, preferably a microorganism with improved L- tryptophan productivity resulted from the inactivation of nrffi gene therein.
- the microorganism producing L-tryptophan can be any microorganism of E. coli, Corynebacterium sp., Serratia sp. or Providencia sp. as long as it can produce L-tryptophan, and preferably E. coli and more preferably E. coli CJ285 (Korean Patent Publication No. 10-2005-0059685) producing L-tryptophan having resistance against tryptophan hydroxamate, the tryptophan analog.
- nrffi gene (NCBI gene ID: 16131900, SEQ. ID. NO: 7) of the present invention is known to be involved in the synthesis, binding and secretion of cytochrome c under anaerobic condition in E. coli.
- the nrffi gene is also confirmed to be required for formate-dependent nitrite reduction along with nrfG gene.
- inactivation indicates the deficiency of nrffi gene having intracellular activity or the mutation of nrffi to reduce the protein level encoded by the gene inside the cell. So, once nrffi gene is inactivated, nrffi expression is decreased.
- the microorganism of the present invention is prepared by inactivating nrffi gene existing in chromosome of a microorganism having L-tryptophan productivity.
- mutation is induced by using a ray such as UV or a chemical.
- a strain having inactivated nrffi gene is selected.
- the inactivation can be performed by DNA recombination technique.
- the inactivation by DNA recombination technique can be achieved by inserting nucleotide sequence or the vector containing the nucleotide sequence having homology with the gene encoding nrffi into a target microorganism to induce homologous recombination.
- the above nucleotide sequence or vector above can include a dominant selection marker.
- the inactivated nrffi gene or its DNA fragment contains polynucleotide sequence having sequence homology with nrffi gene of a host, but this polynucleotide sequence has to have such mutation as truncation of double strand, deletion of base, substitution or insertion of base and inversion of the end so as to be incapable of expressing the protein encoded by nrffi gene.
- the inactivated nrffi gene or its DNA fragment is introduced into a host cell by transformation, the inactivation is induced by mixing the DNA fragment with the strain culture.
- the strain can be transformed due to naturally suitable for the insertion of the DNA, but it is preferable for the strain to be appropriate for the DNA insertion in advance (LeBlanc et al, Plasmid 28, 130-145, 1992; Pozzi et al, J. Bacteriol. 178, 6087-6090, 1996).
- the strain is cultured in LB medium until the early logarithmic phase. The cultured strain is washed with distilled water and 10% glycerol and then concentrated to provide appropriate condition for DNA insertion.
- nrffi gene or its DNA fragment is mutated by deletion of a part of nrffi of the genomic DNA or insertion of a foreign DNA fragment and the wild type chromosome copy of the sequence is inactivated and substituted.
- the nrffi inactivated DNA fragment can inactivate the wild type genome sequence with the tail sequence of the genome DNA by homologous recombination. The inactivation can be confirmed by Southern blotting or more easily by PCR.
- the present invention also provides a method for producing L-tryptophan with high yield by culturing the microorganism whose nrffi is inactivated.
- the culture process of the microorganism can be performed in a proper medium and conditions known to those in the art.
- This culture process can be properly regulated according to the strain selected by those in the art.
- the culture method can be selected appropriately.
- the culture method can be selected from the group consisting of batch, fed-batch and continuous cultures, but not always limited thereto.
- a variety of culture methods are described in the following reference: "Biochemical Engineering” by James M. Lee, Prentice-Hall International Editions, pp 138-176.
- the medium for culture has to meet the culture conditions for a target strain.
- the medium includes various carbon sources, nitrogen sources and trace elements.
- the carbon source is exemplified by carbohydrate such as glucose, sucrose, lactose, fructose, maltose, starch, cellulose; fat such as soybean oil, sunflower oil, castor oil and coconut oil; fatty acid such as palmitic acid, stearic acid, and linoleic acid; alcohol such as glycerol and ethanol; and organic acid such as acetic acid.
- carbohydrate such as glucose, sucrose, lactose, fructose, maltose, starch, cellulose
- fat such as soybean oil, sunflower oil, castor oil and coconut oil
- fatty acid such as palmitic acid, stearic acid, and linoleic acid
- alcohol such as glycerol and ethanol
- organic acid such as acetic acid.
- One of these compounds or a mixture thereof can be used as a carbon
- the nitrogen source is exemplified by such organic nitrogen source as peptone, yeast extract, gravy, malt extract, corn steep liquor (CSL) and bean flour and such inorganic nitrogen source as urea, ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate.
- organic nitrogen source as peptone, yeast extract, gravy, malt extract, corn steep liquor (CSL) and bean flour
- inorganic nitrogen source as urea, ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate.
- the medium herein can additionally include potassium dihydrogen phosphate, dipotassium hydrogen phosphate and corresponding sodium- containing salts as a phosphate source.
- the medium also can include a metal salt such as magnesium sulfate or iron sulfate.
- amino acids, vitamins and proper precursors can be added as well.
- PH of the culture can be adjusted during the cultivation by adding such a compound as ammonium hydroxide, potassium hydroxide, ammonia, phosphoric acid and sulfuric acid.
- the generation of air bubbles can be inhibited during the cultivation by using an antifoaming agent such as fatty acid poly glycol ester.
- oxygen or oxygen-containing gas can be injected into the culture.
- the temperature of the culture is preferably 20 - 45 0 C, more preferably 25 - 4O 0 C.
- the cultivation can be continued until the production of L-tryptophan reaches a wanted level, and the preferable culture time is 10 - 160 hours.
- L-tryptophan can be easily separated from the culture by the conventional method well known to those in the art, which is exemplified by centrifugation, filtration, ion exchange chromatography and crystallization.
- the culture proceeds to low speed centrifugation to eliminate biomass and the obtained supernatant proceeds to ion exchange chromatography for the separation.
- Example 1 Construction of a recombinant microorganism producing L-trvptophan whose nrfE is inactivated [29] In this example, nrffi gene of E. coli was inactivated by homologous recombination.
- the nrffi gene (NCBI gene ID: 1631900) (SEQ. ID. NO: 7) is known to be involved in the synthesis, binding and secretion of cytochrome c in anaerobic condition. It was presumably not necessary for the culture condition for producing L-tryptophan, so that this gene was selected as a target for inactivation to minimize energy loss by unnecessary protein synthesis.
- the nrffi gene is represented by SEQ. ID. NO: 7.
- KCCM Korean Culture Center of Microorganisms
- KFCC Korean Federation of Culture Collection
- International Depository Authority located at 361-221, Hongje-1-Dong, Seodaemungu-Gu, Seoul, Korea, on November 28, 2006 (Accession No: KCCM 10805P).
- Example 2 Comparison of L-tryptophan productivity of the recombinant mi- croorganism whose nrfE is inactivated
- the recombinant strain CO01-0013 (KCCM 10805P) prepared in example 1 was cultured in L-tryptophan flask titer medium comprising the composition shown in Table 4 at 3O 0 C for 48 hours with stirring at 200 rpm.
- the con- centration of tryptophan obtained from the culture and the concentration of tryptophan obtained from the culture of E.coli CJ285 were compared.
- the L-tryptophan concentrations were mean values of three flasks.
- the L-tryptophan productivity can be increased by inactivating nrffi gene of the L-tryptophan producing microorganism according to the method of the present invention. More particularly, the recombinant E. coli CO01-0013 (KCCM 10805P) whose nrffi is inactivated can be prepared from E. coli CJ285 producing L-tryptophan. And the productivity of L-tryptophan can be increased by culturing the recombinant microorganism.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
L'invention concerne un micro-organisme produisant du L-tryptophane, ainsi qu'un procédé de production de L-tryptophane au moyen de ce micro-organisme, et plus particulièrement un micro-organisme recombiné présentant une productivité améliorée de L-tryptophane par inactivation de son gène nrffi codant une nitrite réductase sensible au formiate issue d'E. coli, ainsi qu'un procédé de production de L-tryptophane au moyen dudit micro-organisme.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060126750A KR100850853B1 (ko) | 2006-12-13 | 2006-12-13 | nrfE 유전자가 불활성화된 L-트립토판 생산 미생물 및이를 이용한 L-트립토판 제조방법 |
KR10-2006-0126750 | 2006-12-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008072891A1 true WO2008072891A1 (fr) | 2008-06-19 |
Family
ID=39511863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2007/006462 WO2008072891A1 (fr) | 2006-12-13 | 2007-12-12 | Micro-organisme presentant une activite enzymatique inactivee pour nrfe et procede de production de l-tryptophane au moyen de ce micro-organisme |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100850853B1 (fr) |
WO (1) | WO2008072891A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2801611A4 (fr) * | 2012-01-06 | 2015-10-28 | Cj Cheiljedang Corp | Microorganisme apte à produire un l-acide aminé, et procédé de production d'un l-acide aminé par l'utilisation de celui-ci |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105143440B (zh) | 2013-04-16 | 2019-06-14 | Cj第一制糖株式会社 | 具有l-色氨酸生产力的微生物以及使用所述微生物生产l-色氨酸的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62253391A (ja) * | 1986-04-24 | 1987-11-05 | Ajinomoto Co Inc | 発酵法によるl−トリプトフアンの製造法 |
US5484716A (en) * | 1988-03-04 | 1996-01-16 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing L-tryptophan by a Corynebacterium strain having decreased phosphoenolpyruvate carboxylase activity |
US5756345A (en) * | 1995-09-05 | 1998-05-26 | Degussa Aktiengesellschaft | Production of tryptophan by the bacterium Escherichia coli |
US20060234358A1 (en) * | 2002-05-02 | 2006-10-19 | Britta Anderlei | Method for the microbial production of aromatic amino acids and other metabolites of the aromatic amino acid biosynthetic pathway |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100434108B1 (ko) * | 1996-11-28 | 2004-09-01 | 씨제이 주식회사 | L-트립토판의유전공학적제조방법 |
-
2006
- 2006-12-13 KR KR1020060126750A patent/KR100850853B1/ko active IP Right Grant
-
2007
- 2007-12-12 WO PCT/KR2007/006462 patent/WO2008072891A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62253391A (ja) * | 1986-04-24 | 1987-11-05 | Ajinomoto Co Inc | 発酵法によるl−トリプトフアンの製造法 |
US5484716A (en) * | 1988-03-04 | 1996-01-16 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing L-tryptophan by a Corynebacterium strain having decreased phosphoenolpyruvate carboxylase activity |
US5756345A (en) * | 1995-09-05 | 1998-05-26 | Degussa Aktiengesellschaft | Production of tryptophan by the bacterium Escherichia coli |
US20060234358A1 (en) * | 2002-05-02 | 2006-10-19 | Britta Anderlei | Method for the microbial production of aromatic amino acids and other metabolites of the aromatic amino acid biosynthetic pathway |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2801611A4 (fr) * | 2012-01-06 | 2015-10-28 | Cj Cheiljedang Corp | Microorganisme apte à produire un l-acide aminé, et procédé de production d'un l-acide aminé par l'utilisation de celui-ci |
US10041099B2 (en) | 2012-01-06 | 2018-08-07 | Cj Cheiljedang Corporation | L-threonine and L-tryptophan producing bacteria strain and method of making same |
US10787692B2 (en) | 2012-01-06 | 2020-09-29 | Cj Cheiljedang Corporation | L-threonine and L-tryptophan producing bacteria strain and method of making same |
Also Published As
Publication number | Publication date |
---|---|
KR100850853B1 (ko) | 2008-08-06 |
KR20080054481A (ko) | 2008-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2833104T3 (es) | Cepa que tiene una productividad aumentada de l-valina y método de producción de L-valina mediante el uso de la misma | |
JP6375391B2 (ja) | O−アセチル−ホモセリンを生産する微生物及びこれを用いてo−アセチル−ホモセリンを生産する方法 | |
JP5400065B2 (ja) | 改良されたプロモーターおよびこれを用いたl−リシンの生産方法 | |
JP2019115341A (ja) | L−リジンを生産するコリネバクテリウム属微生物、及びそれを利用したl−リジンの生産方法 | |
JP2018529354A (ja) | L−トレオニンを生産する組み換え微生物及びそれを用いてl−トレオニンを生産する方法 | |
EP1591520B1 (fr) | Microorganisme dans lequel le gène tyrR a été inactivé, méthode pour produire ledit microorganisme et procédé de production de L-thréonine utilisant ledit microorganisme | |
WO2008072891A1 (fr) | Micro-organisme presentant une activite enzymatique inactivee pour nrfe et procede de production de l-tryptophane au moyen de ce micro-organisme | |
EP2430152B1 (fr) | Micro-organisme ayant une productivité de l-lysine améliorée et procédé de production de l-lysine l'utilisant | |
EP3964572A1 (fr) | Mutant de corynebacterium glutamicum ayant une productivité accrue en l-lysine et procédé de préparation de l-lysine utilisant ce mutant | |
KR102285951B1 (ko) | 시트레이트 신타아제의 활성이 약화된 신규한 변이형 폴리펩티드 및 이를 이용한 l-아미노산 생산 방법 | |
JP2017516488A (ja) | O−スクシニルホモセリンまたはコハク酸の生産能を有する微生物、及びそれを利用したコハク酸またはo−スクシニルホモセリンの生産方法 | |
KR100838037B1 (ko) | entC 유전자가 불활성화된 L-트립토판 생산 미생물 및이를 이용한 L-트립토판 제조방법 | |
KR102685486B1 (ko) | L-라이신 생산능이 향상된 변이 미생물 및 이를 이용한 l-라이신의 생산 방법 | |
KR100838036B1 (ko) | yjeO 유전자가 결손된 L-트립토판 생산 미생물 및이를 이용한 L-트립토판 제조방법 | |
CN115261295B (zh) | L-赖氨酸生产能力得到提高的谷氨酸棒状杆菌突变株及利用其的l-赖氨酸的生产方法 | |
EP4083197A1 (fr) | Souche mutante de corynebacterium glutamicum ayant une productivité de l-lysine améliorée et procédé de production de l-lysine l'utilisant | |
KR100798118B1 (ko) | 메틸말로네이트 세미알데하이드 디하이드로게나제 코딩유전자의 기능 결실에 의한 엘-라이신 생산능이 향상된코리네박테리아 및 이를 이용한 엘-라이신 생산 방법 | |
JP2024511393A (ja) | L-シトルリン生産能が向上したコリネバクテリウム・グルタミカム変異株およびこれを用いたl-シトルリンの生産方法 | |
KR20230108790A (ko) | L-히스티딘 생산능이 향상된 에스케리치아 속 변이주 및 이를 이용한 l-히스티딘의 생산 방법 | |
KR20230084993A (ko) | L-라이신 생산능이 향상된 코리네박테리움 글루타미쿰 변이주 및 이를 이용한 l-라이신의 생산 방법 | |
KR20220148694A (ko) | L-라이신 생산능이 향상된 코리네박테리움 글루타미쿰 변이주 및 이를 이용한 l-라이신의 생산 방법 | |
KR20220126610A (ko) | L-라이신 생산능이 향상된 코리네박테리움 글루타미쿰 변이주 및 이를 이용한 l-라이신의 생산 방법 | |
JP2024511329A (ja) | L-リシン生産能が向上したコリネバクテリウム・グルタミカム変異株及びそれを用いたl-リシン生産方法 | |
KR20230108789A (ko) | L-히스티딘 생산능이 향상된 에스케리치아 속 변이주 및 이를 이용한 l-히스티딘의 생산 방법 | |
KR20090092438A (ko) | L-트립토판을 생산하는 미생물 및 이를 이용한l-트립토판 생산 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07851433 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07851433 Country of ref document: EP Kind code of ref document: A1 |